Aequs Limited (AEQUS) has approved a preferential issue of up to 2,80,71,690 warrants, each convertible into one fully paid-up equity share of face value ₹10, to Mellwood Trustee Services Private Limited (Trustee of the Melligeri Private Family Foundation) (“Promoter”). This move aggregates to approximately ₹650 crore and is aimed at funding the company’s aerospace and consumer capacity expansion and supporting its borrowing program.

Significance of the Infusion

The proceeds from this infusion will fund capacity expansion across the aerospace and consumer businesses, including the development of the Hosur facility, investment in subsidiaries and joint ventures supporting that expansion, and general corporate purposes. The equity will also provide the base against which the company raises its term borrowings for the expansion. This infusion aligns the Promoter Group’s economic commitment with the company’s long-term growth plans and capital requirements.

Execution and Timeline

Of the total issue size of approximately ₹650 crore, ₹325 crore will be payable upfront upon allotment of the warrants, representing 50 per cent of the issue size, and twice the regulatory minimum. The balance will be payable upon exercise of the warrants. The warrants may be exercised within 18 months from the date of allotment. Conversion of warrants into equity shares, by making payment of balance consideration, shall take place on or before December 31, 2027. Promoter has undertaken to pay the balance consideration in full, irrespective of the market price of the company’s shares at the time of exercise.

An Extraordinary General Meeting is scheduled on Thursday, October 22, 2026, through video conferencing to seek shareholders’ approval. The detailed terms and conditions of the proposed issue, along with other relevant disclosures, will be made available to shareholders and filed with the stock exchanges in accordance with applicable laws and regulations.

Aravind Melligeri, Executive Chairman & CEO, Aequs Limited, said: “We are winning programmes faster than we had planned for, and those wins need investment ahead of the revenue they bring. This issue gives Aequs committed capital to build that capacity and the equity base to support the borrowing that goes with it. The Promoter Group is subscribing at the price as per SEBI pricing formula and paying half of it upfront — that is the measure of our confidence in what this business can deliver.”

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Aequs Limited

Aequs Limited belongs to the Industrials › Aerospace & Defense sector. Here’s a quick read on where the business and the stock stand today.

Aequs posts a 7.5% three-month gain, but softens in the last few weeks. Margins at 12.4% are middling — adequate but leaving the business with little buffer against cost shocks. 4 loss quarters over five years is a serious red flag — earnings quality is poor and recovery is not guaranteed. The stock gives back 2.2% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. The stock holds up despite 14.8% revenue growth and a PEG of 99.00. That could signal an early turnaround. Alternatively, index flows simply support the price. Watch whether analysts revise estimates upward — that is the real signal. Check Fundamentals of Aequs Limited.

Aequs Limited (AEQUS) gained +5% to near resistance at ₹253 on the NSE on 13 Aug 2026. The move comes as the stock tests the 6M resistance trendline, now just 1.1% away. Aequs, a player in the aerospace and defense sector, is showing strength despite the sector’s mixed performance, indicating that today’s move may be more company-specific than a broad sector rally.

Technical setup — trendlines & DMA

From a technical perspective, Aequs is currently trading above its 6M support trendline at ₹228.15, which is 8.75% below today’s price. The stock is approaching its 6M resistance trendline at ₹253, just 1.1% away. The 50-day moving average (DMA) at ₹224.6 is above the 200-DMA at ₹172.8, signaling a bullish trend. Aequs is currently in the upper third of its 52-week range, suggesting that a significant portion of its potential upside may already be priced in.

Fundamentals & business context

On the fundamental side, Aequs presents a mixed picture. With a revenue CAGR of 15.8% over the past 5 years but a profit CAGR of 0%, the company is growing its top line but not translating that into bottom-line growth. The -12.4% profit margin indicates thin profits, which could be a concern for value-oriented investors. Institutional ownership stands at 13.4%, suggesting that the ‘smart money’ is cautiously optimistic but not overly bullish. There was no specific NSE catalyst today, so the move appears to be driven by technical factors and overall sector sentiment.

Algorithmic scorecard

The algorithmic scorecard paints a picture of a stock that is technically strong but fundamentally weak. The strongest signals come from the bullish trend, with the 50-DMA above the 200-DMA, and the excellent year-to-date performance, which has seen the stock gain 59.1%. These indicators suggest that the stock has been accumulating strength over the past year. However, the weakest signals are the low profit margin of -12.4% and the company’s loss in the last quarter, which are red flags for fundamental investors. The negligible dividend yield of 0% also limits the income potential for yield-seeking investors.

Company outlook

Management provided an optimistic outlook for the full year, expecting 45% to 50% top-line revenue growth with a doubling of operational EBITDA. The consumer segment is expected to reach EBITDA breakeven by Q4 FY27, while the aerospace segment is targeted for 25% to 30% growth and the consumer segment for 125% to 150% growth over FY26. The company is also planning a significant capex of INR660 crores for FY27, with potential acceleration in aerospace capex, and a total capex plan of USD350 million to USD400 million from FY27 to FY31. These initiatives aim to ensure required capacity is available in line with customer timelines and to drive profitable growth in the aerospace segment.

Get all details on AEQUS — P&L, peers, shareholding and more on TradeAlone.

Aequs Limited (AEQUS) extended gains by +5% to ₹244.01 on the NSE today, driven by post-concall momentum following the Q1FY27 earnings release. The stock remains in a consolidating uptrend, with price not yet clearing the 6-month resistance. Aequs, a player in the industrials sector specifically within aerospace and defense, saw its stock rise in a sector that has shown mixed momentum, indicating this move is more company-specific rather than a broader sector rally.

Technical setup — trendlines & DMA

The current 6-month trendline structure shows Aequs stock trading near the support floor of ₹236, which is just 3.27% below today’s price, indicating limited downside risk in the short term. Resistance is set at ₹271.3, which the stock is still 11.18% below, suggesting room for further upside if the consolidation phase continues. The 50-DMA at ₹218.4 is above the 200-DMA at ₹170.0, signaling a positive longer-term trend. The stock is currently in the upper third of its 52-week range, up 81% from its low but still 11.1% below its high, indicating that while much of the potential upside may be priced in, there is still room for growth if the positive momentum continues.

Fundamentals & business context

Aequs’s fundamental picture shows a company with strong revenue growth but facing profitability challenges. The PE ratio is not applicable given the negative profit margins of -12.4%, despite a robust 5-year revenue CAGR of 15.8%. This suggests the market may be pricing in a potential turnaround, though current earnings do not support a high valuation. Institutional ownership stands at 13.4%, indicating a cautious but present interest from smart money. There is no new NSE catalyst today beyond the recent concall, which has driven the current stock movement.

Algorithmic scorecard

Aequs’s overall algorithmic scorecard reflects a technically strong but fundamentally weak profile. The strongest signals include the bullish trend indicated by the 50-DMA being above the 200-DMA, and the bullish sentiment shown by the volume running 2.61x heavier on up days compared to down days over the past month, pointing to systematic accumulation. On the weaker side, the negligible profit margin of -12.4% leaves the company vulnerable to further losses if costs increase, and the recent quarterly loss cautions investors about the near-term financial health of the company.

Company outlook

Aequs is navigating through a period of strong revenue growth but faces profitability challenges. On the strengths side, consolidated revenue grew 55% year-on-year, with significant increases in both aerospace and consumer segments. Operational EBITDA showed a more than three-fold sequential improvement. However, the company reported an EBITDA loss and a PAT loss for Q1 FY’27, mainly due to high depreciation, amortization, and negative cash flow from operations. The consumer segment continues to operate at a loss, though there are signs of improvement.

Management outlined an ambitious outlook for Aequs, targeting 45% to 50% top-line revenue growth for the full year with a doubling of operational EBITDA. The consumer segment is expected to reach EBITDA breakeven by Q4 FY27. Aerospace growth is targeted at 25% to 30%, while consumer growth is projected at 125% to 150% over FY26. The company plans to accelerate its aerospace capex to ensure capacity aligns with customer demand, with a planned capex of INR660 crores for FY27 and a total capex plan of USD350 million to USD400 million from FY27 to FY31. The Hosur facility expansion is set to begin operations by FY29, aiming to enhance production capabilities for engine and landing gear components.

Get all details on AEQUS — P&L, peers, shareholding and more on TradeAlone.